KRM Ayurveda Limited proposes 80-bed South Delhi hospital
Key highlights
- KRM Ayurveda has proposed an approximately 80-bed Ayurveda hospital at East of Kailash, South Delhi.
- The proposed Karma Ayurveda unit is estimated to occupy approximately 4,050 square feet.
- KRM Ayurveda estimates project investment at Rs 2.25 crore to Rs 2.40 crore.
- The hospital is expected to commence shortly, subject to statutory approvals and operational arrangements.
powered by IRIS

KRM Ayurveda has proposed an approximately 80-bed Karma Ayurveda hospital at East of Kailash, South Delhi, with investment estimated at Rs 2.25 crore to Rs 2.40 crore, financed through Initial Public Offering (IPO) proceeds and internal accruals, subject to approvals and operational arrangements.
Know KRM Ayurveda inside out
Results, valuation, peers and who's buying, in one view.
What is KRM Ayurveda proposing in South Delhi?
KRM Ayurveda is proposing a new Ayurveda hospital under the Karma Ayurveda brand, with approximately 80 beds at East of Kailash in South Delhi. The company disclosed the proposal in its 19 November 2026 filing under Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015.
The project is a proposed new facility rather than an enlargement of a named existing hospital. In the annexure to the filing, KRM Ayurveda marked both existing capacity and existing capacity utilisation as not applicable because the 80-bed facility has not yet commenced operations. That means the filing does not provide a pre-project bed base or a percentage increase in company-wide capacity.
KRM Ayurveda said the hospital forms part of its strategy to scale its Ayurveda healthcare business. The company identified four intended outcomes from the project: adding approximately 80 beds, extending its operating footprint into South Delhi, serving demand for Ayurveda-based healthcare services in the region, and deploying IPO proceeds for capacity creation in line with the IPO’s stated objects.
The proposed unit will operate under the Karma Ayurveda brand rather than a newly disclosed brand. KRM Ayurveda described this as brand-led growth in its announcement. The filing does not disclose clinical specialities, staffing levels, doctor appointments, treatment pricing or expected patient volumes for the 80-bed hospital.
Where will the KRM Ayurveda hospital be located and how large will it be?
KRM Ayurveda plans to locate the hospital at D-57, East of Kailash, near Karnataka Bank, South Delhi, in an estimated area of approximately 4,050 square feet. The company described East of Kailash as an established residential and commercial locality and identified the location as a way to enter a South Delhi catchment.
The proposed 80-bed capacity and 4,050-square-foot area are the principal physical metrics disclosed for the site. KRM Ayurveda did not state whether the 4,050 square feet is built-up, carpet or leased area, nor did it disclose the number of floors, consultation rooms, procedure areas or other space allocation within the planned hospital.
Compared with an existing-facility expansion, the disclosed project has no reported utilisation benchmark against which to assess demand or ramp-up. KRM Ayurveda specifically classified existing capacity utilisation as not applicable, while quantifying the new facility’s capacity addition at approximately 80 beds. The filing therefore establishes the scale of the addition but not the occupancy level needed after opening.
Got a follow-up? Ask IRIS
How will KRM Ayurveda fund the 80-bed hospital?
KRM Ayurveda expects the East of Kailash hospital to require approximately Rs 2.25 crore to Rs 2.40 crore, funded through IPO proceeds alongside internal accruals or funds as applicable. The company said the use of IPO funds remains subject to availability, the objects of the IPO and applicable regulatory requirements.
The Rs 2.25 crore to Rs 2.40 crore range indicates a difference of Rs 15 lakh between the lower and upper estimates. KRM Ayurveda did not provide a line-item split between fit-out, equipment, lease-related costs, working capital, technology, licensing or other project costs, so the announcement does not establish how much of the range will be funded by IPO proceeds versus internal accruals.
The company framed use of IPO proceeds as capacity creation rather than as a disclosed acquisition or partnership transaction. Its annexure says the financing will use IPO proceeds in accordance with the IPO objects, along with internal funds where applicable. No borrowing, debt facility, interest cost, equity issue after the IPO or third-party funding arrangement was identified in the 19 November 2026 disclosure.
KRM Ayurveda also did not disclose the balance of available IPO proceeds, any amount already used for other objects, or a committed project budget within the Rs 2.25 crore to Rs 2.40 crore estimate. The stated funding mechanism identifies the intended sources but does not quantify their respective shares or specify a payment schedule for the 80-bed development.
When does KRM Ayurveda expect the hospital to open?
KRM Ayurveda expects the proposed hospital to commence operations shortly, subject to necessary statutory approvals and completion of operational arrangements. The company did not provide a specific opening date, quarter, financial year or construction-completion deadline in the 19 November 2026 announcement.
The stated condition on statutory approvals means commencement is not presented as unconditional. KRM Ayurveda also made operational arrangements a separate prerequisite, without identifying the approvals involved, the approval authorities, the status of applications or the outstanding operational steps required before the approximately 80 beds can be opened.
The filing provides a clear difference between the project’s present and future status: the hospital is proposed now, while operations are expected only after approvals and arrangements are complete. This leaves the timeline dependent on conditions not dated in the disclosure, rather than on a fixed launch target such as a named month or financial year.
KRM Ayurveda said it would make further disclosures to the stock exchange as required under applicable SEBI Listing Regulations. Future updates could clarify approval status, operational commencement, final cost within the Rs 2.25 crore to Rs 2.40 crore range, and actual utilisation of IPO proceeds, but none of those details were confirmed in the current filing.
Conclusion
KRM Ayurveda’s proposed East of Kailash unit would add approximately 80 Ayurveda hospital beds in South Delhi through a site estimated at 4,050 square feet and an investment of Rs 2.25 crore to Rs 2.40 crore. The proposal extends the Karma Ayurveda brand into a new South Delhi location, but the filing supplies no existing-capacity baseline, occupancy data, clinical-service mix or revenue expectation against which to measure its eventual contribution.
The immediate point to watch is whether KRM Ayurveda receives the necessary statutory approvals and completes the operational arrangements required for commencement, which it expects shortly. Subsequent disclosures may also show how the final project cost is allocated between IPO proceeds and internal accruals, because the 19 November 2026 filing sets out the funding sources but not their respective amounts.


